Opportunities for Specialty Drugs in MENA Healthcare Market
December 29, 2022
Introduction Specialty pharmaceuticals are one of the fastest-growing healthcare sectors with a substantial amount of spending by healthcare companies. Although there is no widely agreed-upon definition of specialty drugs, insurers and other health care payers typically define them as expensive prescription products requiring additional handling or administration (such as injection […]

Implications of Industrial Revolution 4.0 on Medical Device Technology in the MENA Region
December 27, 2022
Industrial Revolution 4.0: An Introduction The Industrial Revolution is the transition to a new manufacturing process, shifting the way business operates and use machinery. Technology and machinery have greatly shaped the way modern companies operate, manufacture, and distribute. Modern businesses work due to the fourth industrial revolution, also referred to […]

Hemophilia A: Current players and quick update on emerging therapies in MENA Region
November 17, 2022
Hemophilia A is a genetic disorder quite prevalent across the globe affecting almost every patient population globally. Based on severity, hemophilia A can be classified into three stages: severe (<1% of FVIII in the blood), moderate (1–5% of FVIII in the blood), or mild (6–49% of FVIII in the blood. […]

Manufacturing and Drug Discovery in MENA Region: The Future of Pharmaceuticals
November 3, 2022
The Middle East and North Africa (MENA) region is growing in importance for the global pharmaceutical market. The blog highlights the recent developments in the MENA region and we will cover some of the key trends in the region and take a look at the future of the MENA region […]

Phygital Emotional Intelligence (P-EI)
October 5, 2022
You are all familiar with Emotional Intelligence (EI). Daniel Goleman describes emotional intelligence as a person’s ability to manage his own emotions and feelings so that those emotions and feelings are expressed appropriately and effectively. Goleman writes that emotional intelligence is the largest single predictor of success in the workplace. But what […]

Current Scenario of Genetic Disorders in MENA Region
September 30, 2022
A significant proportion of the population is affected by genetic disorders in the Arab world. According to the Catalogue for transmission genetics in Arab (CTGA), there are 451 genetic disorders in the combined Arab populations of Bahrain, Oman, and the United Arab Emirates (UAE). Given the small populations involved, this […]

Noncommunicable Diseases: A Major Cause of Health Loss and a Burden in the MENA Region
September 30, 2022
Noncommunicable diseases (NCDs) are the leading cause of death across the world. Furthermore, 1 in every 3 adults worldwide suffers from one or more chronic conditions. According to WHO projections, NCDs will account for more than 70% of all deaths worldwide by 2025, with developing countries accounting for 85% of […]

The Opportunity for Generic Drugs in the MENA region
September 13, 2022
Introduction The Middle East and North Africa (MENA) pharmaceutical industry has had impressive growth in recent years and is predicted to reach about US$60 billion by 2025. Out of 19 countries in MENA Region, the pharmaceutical market of Bahrain remains the smallest while the Kingdom of Saudi Arabia (KSA) and […]

Should pharma marketers be slow thinkers?
August 22, 2022
Neuroscientists enjoy organizing human thinking into two parts: right brain vs. left brain, rational vs. emotional, conscious vs. subconscious, and so on. The Nobel Prize winner in Economics, Daniel Kahneman, proposes something totally different. In his book “Thinking, Fast and Slow” he breaks up human thinking: fast vs. slow. He calls […]

Are the drugs of the future traditional drugs or biologics?
July 7, 2022
We are constantly confronted with emerging scientific breakthroughs that make us wonder what the future holds and whether what we have now is still relevant or should be superseded. Consider this… Cassettes were a staple of many of our childhoods growing up in the twentieth century. Audio or video cassettes […]

Molecular Diagnostics (MDx) Market in the MENA Region
June 7, 2022
Introduction Molecular diagnostics (MDx) is the application of the molecular biology technique used in the study of human diseases, including infectious diseases, inherited conditions as well as cancer. The molecular diagnostics research focuses on genomic and proteomic analysis to identify the disease biomarkers, thereby creating better diagnostic assays that ultimately […]

Present Trends in Newborn Screening, Genetic Counseling, and Emerging Drug Therapies in the Effective Treatment of Alpha (α)-Thalassemia in the MENA Region
January 21, 2022
The occurrence of thalassemia is an issue of major concern in the health sector of certain countries, including the Middle East and North Africa (MENA region), Southeast Asia, Central Asia, and the Indian subcontinent. According to DelveInsight’s analysis based secondary sources, countries in the MENA region, particularly the Gulf Cooperation […]

Current Treatment and Development for Spinal Muscular Atrophy (SMA) in MENA region
January 3, 2022
According to the Centre for Arab Genomic Studies, the SMA prevalence in Gulf Cooperation Council (GCC) populations is thought to be at least 50 times higher than in the US, with more than 50 cases per 100,000 live births, compared to only 1.2 in the US. Additionally, various studies conducted […]

Can Headways in Newborn Screening and Emerging Therapies Revamp the Treatment and Diagnosis of Duchene Muscular Dystrophy (DMD) in the MENA Region?
December 16, 2021
Duchenne muscular dystrophy (DMD) is a rare and severe X-linked neuromuscular childhood disorder – predominantly present in males – caused by an absence of dystrophin protein due to mutations of the DMD gene located on the short arm of the X chromosome. Symptoms are usually observed between the ages of 1–6 […]

Overlaying Retinitis Pigmentosa (RP) Management in the MENA Region
November 22, 2021
An analysis of the current scenario and future perspective of Retinitis Pigmentosa epidemiology and management specific to the MENA region! Retinitis Pigmentosa is inherited retinal dystrophy caused by the gradual atrophy of the photoreceptor cells in the retina and characterized by progressive degeneration of the retina and progressive vision loss […]
